Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gengraf Conversion Study
NCT01990118Phase 4Completed
- Sponsor
- Hospital Pulau Pinang
- Start
- Nov 2004
- Primary completion
- Dec 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in kidney transplant rejection (2 arms), sponsored by Hospital Pulau Pinang. Primary endpoint: Serum creatinine level at 26 weeks. Started Nov 2004; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01990118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990118.